A detailed history of Emerald Advisers, LLC transactions in Amgen Inc stock. As of the latest transaction made, Emerald Advisers, LLC holds 2,519 shares of AMGN stock, worth $782,829. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,519
Previous 2,702 6.77%
Holding current value
$782,829
Previous $778,000 7.97%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$268.87 - $324.56 $49,203 - $59,394
-183 Reduced 6.77%
2,519 $716,000
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $690,901 - $779,418
2,702 New
2,702 $778,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.